# Primus Corporation dba Trinity Biotech - Inspection Records

Source: https://www.keypedia.com/companies/primus-corporation-dba-trinity-biotech/df325fd3-9d48-441b-a9f5-54b8401243c5

> Inspection records and compliance data for Primus Corporation dba Trinity Biotech in Kansas City, Missouri. Access full analysis and detailed observations.

---

## Details

- Name: Primus Corporation dba Trinity Biotech
- FEI Number: 1931251
- City: Kansas City
- State: Missouri
- Country Name: United States
- Address Line 1: 4231 E 75th Ter
- Zip Code: 64132

## Related Documents

- [FDA Inspection 1180790 - Primus Corporation dba Trinity Biotech - 2022-09-26](https://www.keypedia.com/records/fda_inspections/primus-corporation-dba-trinity-biotech/c3550808-c01d-420c-9427-4c5eed3f0825) — classification: No Action Indicated (NAI), source: FDA, date: September 26, 2022
- [FDA Inspection 1180790 - Primus Corporation dba Trinity Biotech - 2022-09-26](https://www.keypedia.com/records/fda_inspections/primus-corporation-dba-trinity-biotech/6dd0d9a8-0bc1-48a6-87e3-53966003336f) — classification: No Action Indicated (NAI), source: FDA, date: September 26, 2022
- [FDA Inspection 1154252 - Primus Corporation dba Trinity Biotech - 2021-09-17](https://www.keypedia.com/records/fda_inspections/primus-corporation-dba-trinity-biotech/8f951a89-7e80-4dd6-a434-45e0d1ca4b6a) — classification: No Action Indicated (NAI), source: FDA, date: September 17, 2021
- [FDA Inspection 1154252 - Primus Corporation dba Trinity Biotech - 2021-09-17](https://www.keypedia.com/records/fda_inspections/primus-corporation-dba-trinity-biotech/d88c3399-8472-41e6-bc2f-1d05cc243eef) — classification: No Action Indicated (NAI), source: FDA, date: September 17, 2021
- [483 - Primus Corporation dba Trinity Biotech - 2020-02-06](https://www.keypedia.com/records/483/primus-corporation-dba-trinity-biotech/21d9a69d-3de3-41ac-b392-5d1dd1719520) — source: FDA, date: February 6, 2020
- [WARNING_LETTER - Primus Corporation dba Trinity Biotech - 2020-02-06](https://www.keypedia.com/records/warning_letter/primus-corporation-dba-trinity-biotech/20468464-6d2d-4c66-a80d-b02394382ec7) — source: FDA, date: February 6, 2020
- [FDA Inspection 1117396 - Primus Corporation dba Trinity Biotech - 2020-02-06](https://www.keypedia.com/records/fda_inspections/primus-corporation-dba-trinity-biotech/71d6359a-ee57-4657-a7d4-c107d5cd5302) — classification: Official Action Indicated (OAI), source: FDA, date: February 6, 2020
- [FDA Inspection 1064644 - Primus Corporation dba Trinity Biotech - 2018-09-06](https://www.keypedia.com/records/fda_inspections/primus-corporation-dba-trinity-biotech/77932d7e-eec1-47f3-b4e1-cfcdfd4e8ca1) — classification: Official Action Indicated (OAI), source: FDA, date: September 6, 2018
- [FDA Inspection 1064644 - Primus Corporation dba Trinity Biotech - 2018-09-06](https://www.keypedia.com/records/fda_inspections/primus-corporation-dba-trinity-biotech/ee5cc51e-dec6-42df-b897-645b4eebf91f) — classification: No Action Indicated (NAI), source: FDA, date: September 6, 2018
- [FDA Inspection 912071 - Primus Corporation dba Trinity Biotech - 2015-01-30](https://www.keypedia.com/records/fda_inspections/primus-corporation-dba-trinity-biotech/6dd3a249-03c0-4571-b4b8-0c43215b9a3b) — classification: No Action Indicated (NAI), source: FDA, date: January 30, 2015
- [FDA Inspection 912071 - Primus Corporation dba Trinity Biotech - 2015-01-30](https://www.keypedia.com/records/fda_inspections/primus-corporation-dba-trinity-biotech/9cf309a4-2bce-4777-94eb-3c13ba9c32bc) — classification: No Action Indicated (NAI), source: FDA, date: January 30, 2015
- [FDA Inspection 783015 - Primus Corporation dba Trinity Biotech - 2012-05-18](https://www.keypedia.com/records/fda_inspections/primus-corporation-dba-trinity-biotech/4a899a6d-5863-4966-9591-11f669a03162) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 18, 2012

## Related Companies

- [Philips Respironics, Inc.](https://www.keypedia.com/companies/philips-respironics-inc/03ceee46-7a72-4590-8bc4-8033e1503cf3)
- [Reading Hospital](https://www.keypedia.com/companies/reading-hospital/06325159-9820-479a-ba2e-0f47aaa24d60)
- [Prolacta Bioscience Inc](https://www.keypedia.com/companies/prolacta-bioscience-inc/fafc52a9-8c2a-4c2a-9889-e42779d7c654)
- [Colorado Center for Reproductive Medicine, LC](https://www.keypedia.com/companies/colorado-center-for-reproductive-medicine-lc/ec4fa5b4-cf85-4af1-8e07-b83e0bc8828f)
- [Purdue Pharma L.P.](https://www.keypedia.com/companies/purdue-pharma-lp/12a191f7-7216-4b7c-aa90-a6e20688a346)
- [Biomedix Wai](https://www.keypedia.com/companies/biomedix-wai/35aa0e7f-c8eb-40a8-9b5b-5b57fa435abf)
- [Biomerieux Inc](https://www.keypedia.com/companies/biomerieux-inc/4ca56fd6-0bcf-4144-8cb6-60511d8260b4)
- [Arifulla Khan MD](https://www.keypedia.com/companies/arifulla-khan-md/311edd91-40e3-4296-9283-8ea2b60de005)
- [US Vascular, Inc.](https://www.keypedia.com/companies/us-vascular-inc/32500e78-94f1-4fba-8df5-32eccb7cc967)
- [Nutra Solutions USA, Inc.](https://www.keypedia.com/companies/nutra-solutions-usa-inc/c3b931f1-cf3d-4550-b715-a5e8554a01da)

## Related Officers

- [Investigator ](https://www.keypedia.com/people/christina-l-bigham/f3da8e26-4a8c-43a8-8070-349fe4500289)
- [Director](https://www.keypedia.com/people/blake-bevill/7ed0dcde-28a7-452b-870d-6e085580abde)
- [Donald St. Pierre](https://www.keypedia.com/people/donald-st-pierre/d2e2e0ca-b277-4fbb-9e1a-5c06308531ed)